Ciclopirox Olamine NDC 71335-2915

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2915Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2915Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71335-2915-1	71335291501	1 BOTTLE in 1 CARTON (71335-2915-1) / 30 mL in 1 BOTTLEMarketed from Oct 24, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ciclopirox Olamine
Generic name (nonproprietary): ciclopirox olamine
Active ingredients: Ciclopirox olamine — 7.7 mg/100mL
Dosage form: Suspension
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077676
Marketing start: Dec 29, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Decreased DNA Replication (Physiologic effect)Decreased Protein Synthesis (Physiologic effect)Decreased RNA Replication (Physiologic effect)Protein Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 71335-2915_60371a57-545f-458b-8ca1-016eb9b78629SPL ID 60371a57-545f-458b-8ca1-016eb9b78629SPL set ID 835a6370-f331-4b15-b6fa-beafe027f187RxCUI 309290UNII 50MD4SB4AP

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335291501 followed by a unit qualifier and the quantity

Package 71335-2915-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 24, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; cutaneous candidiasis (moniliasis) due to Candida albicans; and tinea (pityriasis) versicolor due to Malassezia furfur .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077676

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077676
Product	Strength	Form · route	Labeler	Product NDC
Ciclopirox Olamine	Ciclopirox olamine 7.7 mg/100mL	SuspensionTopical	Bryant Ranch Prepack	71335-2717
Ciclopirox Olamine	Ciclopirox olamine 7.7 mg/100mL	SuspensionTopical	Bryant Ranch Prepack	63629-8627
Ciclopirox Olamine	Ciclopirox olamine 7.7 mg/100mL	SuspensionTopical	Bryant Ranch Prepack	72162-1406
Ciclopirox Olamine	Ciclopirox olamine 7.7 mg/mL	SuspensionTopical	Padagis Israel Pharmaceuticals Ltd	45802-400
Ciclopirox Olamine	Ciclopirox olamine 7.7 mg/100mL	SuspensionTopical	Bryant Ranch Prepack	63629-2522